Should I buy Sherwin-Williams (SHW) stock or is it too late?

Sherwin-Williams · Materials · price $345

See the full Sherwin-Williams (SHW) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 64% of its targets hit on this sector (176 calls tested). It aims for $330 (-4.4 %), call made on June 3, 2026, maturing on June 3, 2027 (86 d ago).

The 6 reliable analysts $388+12 %

The 6 other firms $386+12 %

How to read it: the 6 reliable firms are not filtered by optimism — 5 aim above the price, 1 below, hence their $388 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Sherwin-Williams

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
JP Morgan	82 %	+20.9 %	11	$380 +10%
Citigroup	76 %	+20.1 %	17	$380 +10%
Morgan Stanley	71 %	+16.5 %	21	$395 +14%
Mizuho	83 %	+13.9 %	12	$371 +7%
Loop Capital	70 %	+13.1 %	10	$380 +10%
Wells Fargo	54 %	+11.2 %	13	$360 +4%
Evercore ISI Group	45 %	+8.7 %	11	$400 +16%
RBC Capital	52 %	+5.8 %	21	$405 +17%

In short — Should you invest in Sherwin-Williams? Is it too late, still worth it? Analysts are fairly positive (75% buy, median target $388, i.e. +12%), and the most reliable on SHW targets even higher. But the valuation is stretched (P/E ~32). We give you both sides, with the numbers — not advice.

✅ Reasons to believe

75% of analysts rate it a buy (Buy consensus, 12 ratings) — a sign of market conviction.
Median price target $388, i.e. +12% from the current price ($345).
The most reliable firm on SHW, Mizuho (83% hit rate, 12 scored calls), targets $371 (call made on March 23, 2026, maturing on March 23, 2027) (+7%) in its most recent call, and $390 (call made on December 18, 2025, maturing on December 18, 2026) (+13%) in the one coming due soonest.
5 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 12 ratings, 3 are neutral.
High valuation (P/E ~32): strong growth is already "priced in", leaving little room for error.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on SHW

Median target $388 (+12%) · 12 ratings · Buy consensus

Strong Buy00%

Buy975%

Hold325%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Sherwin-Williams now?

We won't decide for you. The facts: 75% of analysts rate it a buy, median target $388 (+12%), and Mizuho (most reliable on SHW, 83%) targets $371. Weigh that against valuation (P/E ~32). This is not personalized advice.

Is it too late to invest in Sherwin-Williams?

Not according to analysts: the median target ($388) is still +12% above the current price ($345) (most reliable on SHW: Mizuho, 83%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Sherwin-Williams still worth investing in?

It depends on the gap between the price ($345) and its estimated value: analysts target $388 on median (+12%), with 75% buys (most reliable on SHW: Mizuho, 83%). Cross-check with their real reliability on SHW and the cautions above. Information, not advice.

What's the main risk in buying SHW?

The consensus is not unanimous: of 12 ratings, 3 are neutral.

→ Go deeper: the full Sherwin-Williams profile (consensus, analyst reliability, price target, performance).